Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 78,759,967
- Total 13F value
- $11,461,957,413
- Share change
- +1,074,121
- Put/Call ratio
- 210%
- SEC-reported price per share
- $145.58
- Number of holders
- 317
- Value change
- +$127,530,777
- Number of buys
- 152
- Number of sells
- 148
- Shares outstanding
- 120,172,375
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
317
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F
Highest disclosed value: $1,546,630,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $1.55B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$1.55B
BlackRock Finance, Inc.
$1.48B
VANGUARD GROUP INC
$1.39B
BAILLIE GIFFORD & CO
$985.17M
MORGAN STANLEY
$847.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$1,546,630,000
7,898,224 shares
|
— | 30 Jun 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$1,478,280,000
7,549,175 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,386,321,000
7,079,569 shares
|
— | 30 Jun 2021 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$985,169,000
5,030,996 shares
|
— | 30 Jun 2021 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$847,479,000
4,327,843 shares
|
— | 30 Jun 2021 |
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$842,033,000
4,300,037 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
317
Shares
78,759,967
Rows available
317
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
332
Q3 2021 holders
317
Holder diff
-15
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|